Ayman Al Haj Zen

Dr. Ayman Al Haj Zen received his Ph.D. in 2006 from the University of Paris VII, where he studied the role of small proteoglycans in the regulation of vascular repair and atherosclerosis. Before joining the University of Oxford in 2010, he was a Postdoctoral Researcher at London Research Institute and the University of Bristol, investigating the role of cell-cell communication signalling in vascular development and regeneration. In Oxford, he was awarded an intermediate research fellowship from the British Heart Foundation (Oxford) Centre of Research Excellence in 2013 to establish his independent research program on therapeutic angiogenesis. 

Dr. Al Haj Zen’s research is focused on the identification of new therapeutic targets and strategies to promote functional neovascularisation and reverse the microvasculature instability in chronic vascular diseases such as peripheral arterial disease. He uses in vitro and in vivo angiogenesis models to understand the role of paracrine signalling occurred between the newly growing microvascular network and the surrounding microenvironment.